# DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC

> **NCT06190665** · NA · RECRUITING · sponsor: **Zhongda Hospital** · enrollment: 188 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DEVICE:** DEB-TACE with visualable microspheres
- **DEVICE:** DEB-TACE with PVA microspheres

## Key facts

- **NCT ID:** NCT06190665
- **Lead sponsor:** Zhongda Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-19
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 188 (ESTIMATED)
- **Last updated:** 2024-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06190665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06190665, "DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06190665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*